Form D · Biotechnology
Molecular Imaging, Inc.
Ann Arbor, MI · CIK 0001519705
Offering snapshot reported Dec 23, 2014 · SEC filing
- Reported sold
- $1.54M Offering amount: $1.54M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $35K Reported outside-investor minimum
- First sale
- Dec 16, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 23, 2014 | Initial | $1,535,000 | No comparison | 5 | SEC filing |
| Oct 2, 2013 | Initial | $3,500,000 | No comparison | 5 | SEC filing |
| May 11, 2011 | Initial | $7,000,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-230791
Source: Form D, filed Dec 23, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Dougherty | Director |
| Mark Eisenach | Director |
| Michael Gross | Director, Executive |
| Thomas Ludlam | Director, Executive |
| Peter Shagory | Director, Executive |
| Stephen Sullivan | Director |
| Steven Sullivan | Director |
| Nicole Walker | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
800 Technology Drive
Ann Arbor, MI, 48108
Ann Arbor, MI, 48108